Orbital radiotherapy for Graves’ ophthalmopathy

Thyroid

Volumn 12, Issue 3, 2002, Pages 245-250

  Bartalena, Luigi ^a   Marcocci, Claudio ^b   Tanda, Maria Laura ^b   Rocchi, Roberto ^b   Mazzi, Barbara ^b   Barbesino, Giuseppe ^b   Pinchera, Aldo ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DIABETIC RETINOPATHY; DRUG MEGADOSE; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LINEAR ACCELERATOR; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE; SAFETY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

GRAVES DISEASE; HUMANS; ORBIT;

EID: 0036210862     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502753600223     Document Type: Article

References (49)

1. Management of Graves' ophthalmopathy: Reality and perspectives
2. Treating severe Graves' ophthalmopathy
3. Radiotherapy of Graves' ophthalmopathy
4. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management
5. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy
6. Orbital radiotherapy for Graves' ophthalmopathy
7. Graves' ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids
8. Prognostic factors in the radiotherapy of Graves' ophthalmopathy
9. Low-versus high-dose radiotherapy for Graves' ophthalmopathy: A randomized single blind trial
10. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy
11. Orbital irradiation in the treatment of Graves' ophthalmopathy
12. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy. A novel approach
13. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy
14. Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids
15. Synergism between diabetic and radiation retinopathy: Case report and review
16. Supervoltage orbital radiotherapy for Graves' ophthalmopathy
17. Radiation therapy for exophthalmos: Report of seven cases
18. Dysthyroid optic neuropathy
19. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy
20. Zur Strahlentherapie der endokriner Orbitopathie
21. Ergebnisse der Retrobulbarbestrahlung bei benigner endokriner Ophthalmopathie
22. Treatment of Graves' ophthalmopathy by steroid therapy orbital irradiation therapy plasmapheresis and thyroxine replacement
23. Radiation therapy for Graves' disease
24. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone
25. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: A comparative study
26. Radiotherapy of severe ophthalmic Graves' disease
27. Radiation therapy for thyroid eye disease
28. Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results
29. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy
30. Radiation therapy for Graves' ophthalmopathy: A retrospective analysis
31. Therapeutic outcome of prednisone medication and orbital irradiation in patients with Graves' ophthalmopathy
32. Results of radiotherapy for thyroid ophthalmopathy
33. Radiotherapy in emergency treatment of malignant exophthalmos
34. Supervoltage orbital radiotherapy in 36 cases of Graves' disease
35. Radiotherapy in the management of thyroid orbitopathy
36. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
37. Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance
38. Radiotherapy for severe progressive thyroid-associated ophthalmopathy: Long-term results with comparison of scoring systems
39. Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study
40. A prospective double-blind placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy
41. Radiation therapy for Graves' ophthalmopathy: Trick or treat?
42. Orbital radiotherapy combined with high-dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective study
43. Retrobulbar radiation in Graves' ophthalmopathy
44. A clinical study of radiation cataracts and the relationship to dose
45. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy
46. Radiation and Graves' ophthalmopathy
47. Is there a risk of retinopathy after retrobulbar radiotherapy for Graves' ophthalmopathy?
48. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy
49. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy